October 2024 – Page 26

Pharmaceutical Giants J&J and Bayer Announce Layoffs of Nearly 300 Employees in New Jersey

7 months ago talkbio0Tagged Bayer, Drug Industry, Johnson and Johnson, New Jersey

Johnson & Johnson, Bayer, layoffs, New Jersey, pharmaceutical industry, job cuts

Frazier Life Sciences Boosts Evergreen Fund with $630M for Small and Mid-Cap Biotechs

7 months ago talkbio0Tagged Biotechnology, biotechs, Evergreen Fund, Frazier Life Sciences, Health care facility, Mid-Cap, Small

Frazier Life Sciences, Evergreen Fund, Small and Mid-Cap Biotechs, Healthcare Investment, Biotechnology Funding

Comparative Efficacy of J&J’s Erleada and Astellas/Pfizer’s Xtandi in Non-Metastatic Prostate Cancer: Real-World Study Insights

7 months ago talkbio0Tagged apalutamide, Comparative Efficacy, enzalutamide, Erleada, Malignant neoplasm of prostate, nmCRPC, non-metastatic castration-resistant prostate cancer, profiles, Real-World Study, Safety

Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), Erleada (Apalutamide), Xtandi (Enzalutamide), Real-World Study, Comparative Efficacy, Safety Profiles

FDA Panel Recommends Limiting Immunotherapy Access for Stomach and Esophageal Cancer Patients Based on PD-L1 Expression

7 months ago talkbio0Tagged Esophageal Neoplasms, Gene Expression, Immunotherapy, Keytruda, Malignant neoplasm of stomach, PD-L1, Tevimbra, United States Food and Drug Administration

FDA, Immunotherapy, Stomach Cancer, Esophageal Cancer, PD-L1 Expression, Keytruda, Opdivo, Tevimbra

GE HealthCare’s Flyrcado (flurpiridaz F 18) PET Radiotracer Receives FDA Approval for Enhanced Detection of Coronary Artery Disease

7 months ago talkbio0Tagged Approved, Cardiac imaging, Coronary Arteriosclerosis, F 18, Flyrcado, Health care facility, nuclear cardiology, Pet Animal, Radiotracers, United States Food and Drug Administration

GE HealthCare, Flyrcado, flurpiridaz F 18, PET radiotracer, Coronary artery disease (CAD), FDA approval, Cardiac imaging, Nuclear cardiology

Big Pharma’s Layoff Wave Continues in New Jersey: J&J and Bayer Announce Significant Job Cuts

7 months ago talkbio0Tagged Bayer, Big Pharma layoffs, Drug Industry, Johnson & Johnson, New Jersey, restructuring

Big Pharma layoffs, New Jersey, Johnson & Johnson, Bayer, pharmaceutical industry restructuring

Remedee Labs Secures European Approval for Groundbreaking Fibromyalgia Wristband Therapy

7 months ago talkbio0Tagged Approved, endorphin stimulation, European (ethnic group), Fibromyalgia, millimeter-wave technology, Non-Pharmaceutical, Remedee Labs, wristband therapy

Remedee Labs, fibromyalgia, wristband therapy, European approval, non-pharmaceutical treatment, millimeter-wave technology, endorphin stimulation

Amgen Faces Investor Lawsuit Over $10.7 Billion Tax Liability

7 months ago talkbio0Tagged amgen, investor, Legal

Amgen, investor lawsuit, tax liability, $10.7 billion, legal challenge

IGM Biosciences Undergoes Strategic Pivot to Autoimmune Diseases, Overhauls Leadership and Reduces Workforce

7 months ago talkbio0Tagged Autoimmune Diseases, Biosciences, Changing, Immunoglobulin M, imvotamab, Leadership, strategic pivot, T cell-engaging IgM antibodies

IGM Biosciences, autoimmune diseases, strategic pivot, T cell-engaging IgM antibodies, leadership changes, workforce reduction, imvotamab, IGM-2644

Bristol Myers Squibb Invests $110 Million in T-Cell Therapy Pact with Prime Medicine

7 months ago talkbio0Tagged biotech, BMS, Burning Mouth Syndrome, ex vivo, Investments, Myers, pharmaceutical partnerships, Prime Medicine, squibb, T-cell therapy

Bristol Myers Squibb (BMS), Prime Medicine, T-cell therapy, Ex vivo therapies, Biotech investment, Pharmaceutical partnerships